Molina Healthcare (NYSE:MOH – Free Report) had its target price cut by Wells Fargo & Company from $235.00 to $220.00 in a research report sent to investors on Tuesday, Marketbeat Ratings reports. They currently have an equal weight rating on the stock.
A number of other research analysts have also issued reports on MOH. Mizuho set a $215.00 price target on shares of Molina Healthcare in a research note on Monday, June 8th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $129.00 price objective on shares of Molina Healthcare in a research note on Friday, April 24th. Wall Street Zen raised Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Saturday, May 2nd. Jefferies Financial Group set a $230.00 target price on Molina Healthcare in a research note on Tuesday, July 14th. Finally, Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price target for the company in a research report on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $202.44.
Read Our Latest Analysis on MOH
Molina Healthcare Price Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.12. The business had revenue of $10.87 billion for the quarter, compared to analyst estimates of $10.83 billion. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The company’s revenue was down 4.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.48 earnings per share. As a group, equities analysts expect that Molina Healthcare will post 5.29 EPS for the current fiscal year.
Insider Buying and Selling at Molina Healthcare
In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the sale, the insider directly owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. This trade represents a 20.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares of the company’s stock, valued at $2,454,713.25. The trade was a 4.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 1.44% of the company’s stock.
Institutional Trading of Molina Healthcare
A number of hedge funds have recently modified their holdings of the stock. Elevation Wealth Partners LLC raised its position in Molina Healthcare by 118.2% during the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock valued at $33,000 after acquiring an additional 78 shares in the last quarter. Torren Management LLC purchased a new stake in Molina Healthcare in the 4th quarter worth approximately $26,000. MUFG Securities EMEA plc acquired a new stake in shares of Molina Healthcare during the 2nd quarter worth approximately $48,000. Cromwell Holdings LLC grew its stake in shares of Molina Healthcare by 211.9% during the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after purchasing an additional 125 shares during the period. Finally, Quarry LP purchased a new position in shares of Molina Healthcare during the 4th quarter valued at approximately $32,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Further Reading
- Five stocks we like better than Molina Healthcare
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
